Showing results (241-250 of 369) with videos related to
Sort By:
Pageof 37
Medical Oncology (Northwood, London, England)|April 15, 2010
Chemotherapy in clear cell sarcomaRobin L Jones, Anastasia Constantinidou, Khin Thway, et al.Journal for Immunotherapy of Cancer|April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapyBrett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.Clinical Sarcoma Research|January 9, 2020
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centreFlorence Chamberlain, Sheima Farag, Constance Williams-Sharkey, et al.Journal of Adolescent and Young Adult Oncology|May 8, 2020
Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center ExperienceEugenie Younger, Olga Husson, Bernice Asare, et al.Plos One|March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabineSeth M Pollack, Yonqing Li, Megan J Blaisdell, et al.JCO Global Oncology|June 30, 2021
What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across ScotlandHolly M McCabe, Alannah Smrke, Fiona Cowie, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumorsRobin L Jones, Edward S Kim, Pilar Nava-Parada, et al.Cancers|May 27, 2026
A Predictive MRI Radiomics Model for Histologic Differentiation in Soft Tissue SarcomasLaetitia Perronne, Nicolò Gennaro, Zuzanna Kobus, et al.The Journal of Molecular Diagnostics : JMD|April 3, 2022
The Neoantigen Landscape of the Coding and Noncoding Cancer Genome SpaceTammy T Y Lau, Zahra J Sefid Dashti, Emma Titmuss, et al.British Journal of Cancer|March 10, 2020
Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre studyHans Gelderblom, Robin L Jones, Suzanne George, et al.Pageof 37